Skip to content

Released Aug 7, 2025, after the close

10-Q filed Aug 8, 2025, 39 days after period end · 0001636422-25-000111

Q2 2025 · 10-Q
Revenue$80.72M+6.3% vs Q2 2024+1.6% vs Q1 2025
Net Income-$40.98MN/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$0.59N/M vs Q2 2024N/M vs Q1 2025
Operating Income-$37,094,000N/M
Operating Cash Flowderived-$8,997,000N/M
Free Cash Flowderived-$8,767,000N/M
Margins · derived
Operating margin-46.0%−25.1 pt vs Q2 2024
Net margin-50.8%−33.0 pt vs Q2 2024

What the release said

The release

Same quarter

MetricQ2 2025Q2 2024Q2 2023Q2 2022
Revenue$80.72M$75.90M$73.21M$70.63M
Net Income-$40.98M-$13.52M-$32.61M-$33.43M
EPS Diluted-$0.59-$0.23-$0.58-$0.62

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR